We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$90.5B
1-Year Est. Return
33.95%
This Fund
S&P 500
This Quarter
Est. Return
+23.44%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$90.5B
AUM Growth
+$5.41B
(+6.4%)
Cap. Flow
-$1.73B
Cap. Flow
% of AUM
-1.91%
Top 10 Holdings %
Top 10 Hldgs %
20.12%
Holding
5,141
New
939
Increased
1,573
Reduced
1,769
Closed
818
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$732M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$553M |
| 3 |
Applied Materials
AMAT
|
+$327M |
| 4 |
Intuit
INTU
|
+$320M |
| 5 |
Chevron
CVX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$651M |
| 3 |
Microsoft
MSFT
|
+$344M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$298M |
| 5 |
Qualcomm
QCOM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.2% |
| 2 | Technology | 14.41% |
| 3 | Healthcare | 5.76% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Gossamer Bio
GOSS
$85.7M
| $421K | ﹤0.01% |
2,556,378
-842,379
| -25% | -$235K |
|
3527
CytomX Therapeutics
CTMX
$808M
| $421K | ﹤0.01% |
112,152
-129,063
| -54% | -$493K |
|
3528
Novartis
NVS
$304B
| $419K | ﹤0.01% |
2,676
-11,287
| -81% | -$1.69M |
|
3529
Outdoor Holding Co
POWW
$252M
| $419K | ﹤0.01% |
183,835
+128,970
| +235% | +$266K |
|
3530
PUT
ACM Research
ACMR
$5.18B
| $419K | ﹤0.01% |
+3,300
| New | +$233K |
|
3531
First National Corp
FXNC
$286M
| $419K | ﹤0.01% |
13,942
-10,088
| -42% | -$286K |
|
3532
CALL
Ecolab
ECL
$78.3B
| $418K | ﹤0.01% |
1,500
-900
| -38% | -$237K |
|
3533
PUT
Vicor
VICR
$8.69B
| $418K | ﹤0.01% |
1,100
-5,900
| -84% | -$1.61M |
|
|
AIV
3534
Aimco
AIV
$372M
| $417K | ﹤0.01% |
140,395
-198,812
| -59% | -$762K |
|
3535
ProShares UltraShort Dow 30
DXD
$46.6M
| $417K | ﹤0.01% |
+24,276
| New | +$462K |
|
3536
CALL
First Citizens BancShares
FCNCA
$24.9B
| $416K | ﹤0.01% |
200
-3,000
| -94% | -$6.02M |
|
3537
PUT
GitLab
GTLB
$8.3B
| $415K | ﹤0.01% |
13,600
-17,800
| -57% | -$451K |
|
3538
California Water Service
CWT
$3.09B
| $415K | ﹤0.01% |
8,527
-40,489
| -83% | -$1.83M |
|
3539
Fate Therapeutics
FATE
$297M
| $415K | ﹤0.01% |
+153,624
| New | +$284K |
|
3540
Morgan Stanley Direct Lending Fund
MSDL
$1.28B
| $415K | ﹤0.01% |
27,425
-5,183
| -16% | -$78.5K |
|
|
WSE
3541
Wise Group
WSE
$12.6B
| $415K | ﹤0.01% |
+34,816
| New | +$416K |
|
3542
CALL
Factset
FDS
$10.7B
| $414K | ﹤0.01% |
1,800
-16,000
| -90% | -$3.67M |
|
3543
Annaly Capital Management
NLY
$17.2B
| $413K | ﹤0.01% |
+18,477
| New | +$408K |
|
3544
Indivior Pharmaceuticals
INDV
$4.12B
| $413K | ﹤0.01% |
+10,058
| New | +$365K |
|
3545
Titan Machinery
TITN
$617M
| $411K | ﹤0.01% |
19,466
-86,692
| -82% | -$1.78M |
|
3546
CALL
Biogen
BIIB
$32.6B
| $411K | ﹤0.01% |
+1,900
| New | +$363K |
|
3547
CALL
American Electric Power
AEP
$67.8B
| $410K | ﹤0.01% |
3,000
-26,000
| -90% | -$3.43M |
|
3548
Hafnia
HAFN
$4.61B
| $410K | ﹤0.01% |
+61,763
| New | +$500K |
|
3549
PUT
Pool Corp
POOL
$6.73B
| $408K | ﹤0.01% |
1,900
-4,300
| -69% | -$858K |
|
3550
CALL
AerCap
AER
$22.9B
| $408K | ﹤0.01% |
+2,800
| New | +$398K |
|
Similar funds
VM
Squarepoint's Q2 2026 Portfolio in Review
As of Q2 2026, Squarepoint held 5,141 positions worth $90.5B, up 6.4% from $85.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Squarepoint's Q2 2026 filing shows 939 new, 1,573 increased, 1,769 reduced and 818 closed positions. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M. The largest sale was iShares Core S&P 500 ETF, an estimated $3.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
- Squarepoint's largest Q2 2026 buy was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $732M increase.
- Squarepoint's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $3.03B.
- Squarepoint fully exited VanEck Semiconductor ETF in Q2 2026, selling an estimated $192M.
- Squarepoint's ten largest holdings make up 20% of its $90.5B portfolio in Q2 2026.
- Squarepoint opened 939 new positions and closed 818 in Q2 2026.
- Squarepoint's portfolio value rose 6.4% quarter-over-quarter to $90.5B.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.